Leptin, superoxide dismutase, and weight loss: Initial leptin predicts weight loss

被引:18
作者
Shih, Ling-Ying
Liou, Tsan-Hon
Chao, Jane C. -J.
Kau, Hsin-Nung
Wu, Yi-Jiun
Shieh, Ming-Jer
Yeh, Ching-Ying
Han, Bor-Cheng
机构
[1] Taipei Med Univ, Sch Publ Hlth, Taipei 110, Taiwan
[2] Taipei Med Univ, Sch Pharm, Grad Inst Pharm, Taipei, Taiwan
[3] Taipei Med Univ, Municipal Wan Fang Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan
[4] Taipei Med Univ, Municipal Wan Fang Hosp, Obes Res Ctr, Taipei, Taiwan
[5] Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan
关键词
weight reduction; fat mass; BMI; leptin; superoxide dismutase activity;
D O I
10.1038/oby.2006.256
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Our goal was to study how plasma leptin concentration, superoxide dismutase (SOD) activity, and weight loss are related in obese adults. Research Methods and Procedures: Serum leptin concentration, SOD activities, general biochemical data, and body composition measurements were obtained for 62 overweight and obese subjects before and after an 8-week body weight reduction (BWR) regimen. The subjects were on dietary control, performed moderate aerobic and strength training exercises, and attended educational lectures. Results: The measurement results indicated that the following criteria were significantly reduced: body weight [84.4 +/- 17.0 vs. 79.3 +/- 16.1 (standard error) kg, p < 0.001]; BMI (31.5 +/- 4.3 vs. 29.4 +/- 4.2 kg/m(2), P < 0.001), and fat mass (33.3 +/- 10.0 vs. 29.8 +/- 10.4 kg, p < 0.001). Plasma leptin levels also significantly decreased from 31.5 +/- 17.6 to 26.5 +/- 17.2 ng/mL (p < 0.001). Additionally, SOD activity was significantly increased from 261.4 +/- 66.0 to 302.7 +/- 30.9 U/mL (p < 0.001). Based on linear regression analysis results, a 3.78- to 8.13-kg reduction in weight can be expected after the 8-week BWR regimen when initial leptin concentration was 5 to 30 ng/mL. Discussion: We found that an 8-week exercise and diet program was effective in reducing weight and fat mass and, notably, had further beneficial effects on leptin resistance and SOD activity. Additionally, this study demonstrated that initial plasma leptin concentration may be used as a predictor for weight loss outcome.
引用
收藏
页码:2184 / 2192
页数:9
相关论文
共 41 条
[1]  
Aaseth J., 1986, HDB TOXICOLOGY METAL, VII, P233
[2]   Role of leptin on alcohol-induced oxidative stress in Swiss mice [J].
Balasubramaniyan, V ;
Sailaja, JK ;
Nalini, N .
PHARMACOLOGICAL RESEARCH, 2003, 47 (03) :211-216
[3]   Increase of anti-oxidation by exercise in the liver of obese Zucker rats [J].
Chang, SP ;
Chen, YH ;
Chang, WC ;
Liu, IM ;
Cheng, JT .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (08) :506-511
[4]   Serum immunoreactive leptin concentrations in normal-weight and obese humans [J].
Considine, RV ;
Sinha, MK ;
Heiman, ML ;
Kriauciunas, A ;
Stephens, TW ;
Nyce, MR ;
Ohannesian, JP ;
Marco, CC ;
McKee, LJ ;
Bauer, TL ;
Caro, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :292-295
[5]   Leptin serum concentrations predict the responsiveness of obese children and adolescents to weight excess reduction program [J].
Di Stefano, G ;
Bini, V ;
Papi, F ;
Celi, F ;
Contessa, G ;
Berioli, MG ;
Bacosi, ML ;
Falorni, A .
INTERNATIONAL JOURNAL OF OBESITY, 2000, 24 (12) :1586-1591
[6]   Leptin and the regulation of body weight in mammals [J].
Friedman, JM ;
Halaas, JL .
NATURE, 1998, 395 (6704) :763-770
[7]   Pivotal role of nitric oxide in the control of blood pressure after leptin administration [J].
Frühbeck, G .
DIABETES, 1999, 48 (04) :903-908
[8]   Effects of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes [J].
Giannopoulou, I ;
Fernhall, B ;
Carhart, R ;
Weinstock, RS ;
Baynard, T ;
Figueroa, A ;
Kanaley, JA .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (07) :866-875
[9]   Leptin concentrations in diabetic and nondiabetic Mexican-Americans [J].
Haffner, SM ;
Stern, MP ;
Miettinen, H ;
Wei, M ;
Gingerich, RL .
DIABETES, 1996, 45 (06) :822-824
[10]  
JERZY B, 2003, ATHEROSCLEROSIS, V170, P21, DOI DOI 10.1016/S0021-9150(03)00236-3